BGI Genomics: As of July 31, a total of 93.5832 million yuan worth of shares have been repurchased.

BGI Genomics announced that on June 10, 2026, the company agreed to repurchase shares through centralized bidding for the purpose of an employee stock ownership plan or equity incentives, with a repurchase amount between 250 million yuan and 500 million yuan, valid until June 9, 2027. In July 2026, the company had cumulatively repurchased 1.2523 million shares, accounting for 0.30% of the total share capital, with a payment amount of 62.5376 million yuan. As of July 31, the company had cumulatively repurchased 1.8799 million shares, accounting for 0.45% of the total share capital, with a total payment amount of 93.5832 million yuan, at a transaction price ranging from 46.86 yuan/share to 59.21 yuan/share.